Literature DB >> 17592256

Gastrointestinal stromal tumors: diagnostic challenges and practical approach to differential diagnosis.

Richard Kirsch1, Zu-Hua Gao, Robert Riddell.   

Abstract

Over the last decade, gastrointestinal stromal tumors (GISTs) have evolved from histogenetically obscure gastrointestinal mesenchymal tumors to well-defined tumors with distinctive clinical, morphologic, ultrastructural, histogenetic, and molecular characteristics, for which targeted therapy is available. This is largely attributable to the discovery of CD117 overexpression and activating mutations in c-kit or platelet-derived growth factor alpha genes in most of GISTs. The availability of specific diagnostic tests and targeted therapy for GISTs has led to an increased awareness of these tumors. At the same time, the list of potential GIST mimics has lengthened considerably and it has become increasingly important that GISTs be distinguished from their mimics because correct diagnosis has implications for both treatment and prognosis. The purpose of this review is to provide an update of the expanding differential diagnosis of GISTS, to draw attention to unusual GIST variants, to provide a practical approach the differential diagnosis of GISTs and to highlight some of the challenges faced by pathologists in resolving this differential diagnosis.

Entities:  

Mesh:

Year:  2007        PMID: 17592256     DOI: 10.1097/PAP.0b013e3180ca826a

Source DB:  PubMed          Journal:  Adv Anat Pathol        ISSN: 1072-4109            Impact factor:   3.875


  9 in total

Review 1.  Gastrointestinal stromal tumors (GISTs): an updated experience.

Authors:  Anastasios Machairas; Eva Karamitopoulou; Dimitrios Tsapralis; Theodore Karatzas; Nickolas Machairas; Evangelos P Misiakos
Journal:  Dig Dis Sci       Date:  2010-08-20       Impact factor: 3.199

2.  Inflammatory fibroid polyp of the small bowel with a mutation in exon 12 of PDGFR alpha.

Authors:  Silvia Calabuig-Fariñas; José Antonio López-Guerrero; M Jesús Nicolau Ribera; Samuel Navarro; David Ramos; Antonio Pellín; Antonio Llombart-Bosch
Journal:  Virchows Arch       Date:  2009-02-03       Impact factor: 4.064

Review 3.  Primary gastrointestinal stromal tumors: Current advances in diagnostic biomarkers, prognostic factors and management of its duodenal location.

Authors:  Yuesi Zhong; Meihai Deng; Bo Liu; Cheng Chen; Mingliang Li; Ruiyun Xu
Journal:  Intractable Rare Dis Res       Date:  2013-02

Review 4.  Gastrointestinal stromal tumours at present: an approach to burning questions.

Authors:  Manuel García de Polavieja Carrasco; Ana de Juan Ferré; Marta Mayorga Fernández
Journal:  Clin Transl Oncol       Date:  2010-02       Impact factor: 3.405

5.  Role of imatinib in the management of early, operable, and advanced GI stromal tumors (GISTs).

Authors:  John T Vetto
Journal:  Onco Targets Ther       Date:  2009-02-18       Impact factor: 4.147

Review 6.  Imatinib in the treatment of solid tumours.

Authors:  Florence Duffaud; Axel Le Cesne
Journal:  Target Oncol       Date:  2009-01-27       Impact factor: 4.493

7.  Gastrointestinal stromal tumor.

Authors:  Xiaohui Zhao; Changjun Yue
Journal:  J Gastrointest Oncol       Date:  2012-09

8.  Endoscopic versus open resection for small gastric gastrointestinal stromal tumors: safety and outcomes.

Authors:  Chaoyong Shen; Haining Chen; Yuan Yin; Jiaju Chen; Luyin Han; Bo Zhang; Zhixin Chen; Jiaping Chen
Journal:  Medicine (Baltimore)       Date:  2015-01       Impact factor: 1.889

9.  A Case of Malignant Gastrointestinal Stromal Tumor Initially Misdiagnosed as Malignant B-Cell Lymphoma.

Authors:  Byoung Jo Suh
Journal:  Case Rep Oncol       Date:  2016-06-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.